DelveInsight’s “Prefilled Syringes Market Insights, Competitive Landscape and Market Forecast-2026” report delivers an in-depth understanding of the Prefilled Syringes, historical and forecasted epidemiology as well as the Prefilled Syringes market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Recent developmental activities in Prefilled Syringes market
According to DelveInsight, the pre-filled syringe market will increase at a CAGR of 10.40 percent during the forecasted period from 2021 to 2026, to reach USD 18.76 billion by 2026.
In July 2021, Fresenius Kabi launched ready-to-administer prefilled fentanyl syringe in the 1 ml volume format which is designed to cut waste and diversion by eliminating the possibilities of potential errors.
In May 2021, Glenmark Pharmaceuticals Limited received the US Food and Drug Administration approval for the Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe.
In April 2021, Roche received the approval from the US FDA for the supplemental Biologics License Application of the company for Xolair® (omalizumab) prefilled syringe for self-injection across all approved U.S. indications.
In March 2021, Zealand Pharma announced the US FDA approval for the Zegalogue® (dasiglucagon) injection which is available in the prefilled syringe form, for the treatment of diabetes.
For more insights into Prefilled Syringes Market, get the snapshot of the key highlights entailed in the Prefilled Syringes Report
Prefilled Syringes Overview
A prefilled syringe is a single-dose packet of vaccines to which a needle has been fixed by the manufacturer. In the past metal or glass syringes were popular, but increasingly there has been a movement towards plastic and disposable syringes so the needle is protected and cannot be reused (prefilled disposable systems). This has stimulated the demand for convenient and safe prefilled syringes.
Prefilled syringes have been around for more than two decades. Prefilled syringe manufacturers have had to therefore respond to increasing demand, new requirements and more sophisticated forms of drug delivery. There has been great development in syringes. New products are being put in syringes now. Prefilled syringes are used to package injectable drugs and diluents. Some of the categories of drugs packaged in prefilled syringes are vaccines, blood stimulants, therapeutic proteins, erythro proteins, interferons, and rheumatoid arthritis.
Geography Wise- Prefilled Syringes Market Analysis
The Blood Glucose Monitoring System market is analyzed geographically for North America, Europe, Asia-Pacific, and the Rest of the World.Among all the regions, North America is expected to account for the significant market share in the prefilled syringes market because of the high prevalence of autoimmune disorders, chronic diseases, rising population of the elderly as well as high awareness among people regarding disease management and the new product launches in the region.
The North American prefilled syringes market is witnessing an upward trend due to the rising prevalence of autoimmune diseases among other factors. In a study published in the journal Arthritis and Rheumatology by Dinse et al. in 2020, the researchers found that the prevalence of antinuclear antibodies (ANA), the most common biomarkers of autoimmunity, is increasing significantly in the United States in general, and more specifically in certain groups. Therefore, in order to cater to the medical needs of the large population suffering from autoimmune diseases such as RA, a number of medications are available in the prefilled syringes form. The well-established patient care system along with awareness among patients and caregivers regarding different types of prefilled syringes is further expected to propel the North American prefilled syringes market growth.
By Product Design
Staked Needle System
Luer Cone System,
Luer Lock System
By End User
Hospitals & Clinics
Ambulatory Surgical Centers
Rest of the World
Get a sneak peek at the Prefilled Syringes Market market dynamics @ Prefilled Syringes Market Drivers Analysis
Prefilled Syringes Market Segment Analysis
In the material segment of the prefilled syringes market, there is expected to be a shift from glass to polymer (plastic) syringes in the forecast period in order to overcome the shortcomings of the prefilled syringes made of glass. For instance, silicone oil (used to lubricate the inner surface of glass pre-filled syringe) is seen as a key factor which cannot be avoided in the manufacture of glass prefilled syringes yet is known to interfere with the properties of the biologics. Silicone is needed to ensure functionality, for components for prefilled syringes such as the plunger but silicone can alter sensitive proteins under certain conditions—causing them to aggregate or change their form. Therefore, polymer prefilled syringes are now being preferred over the glass prefilled syringes. The polymer prefilled syringes have high barrier properties against water vapor and oxygen, thereby effectively protecting the contents of the syringe. These syringes are also transparent, and are remarkably similar in appearance to glass syringes. This transparency also makes it easy to visually check content for haze, particles, and other imperfections. The Cyclo-Olefin-Polymer (COP) syringes are also much more resistant to breakage than their glass counterparts. Thus, the factors mentioned above are going to be instrumental in the increasing demand for plastic prefilled syringes in the forecast period.
Prefilled Syringes Market Scope
Study Period: 2018-2026
Key Companies: BD, NIPRO Pharma, Taisei Kako Co.,Ltd, TERUMO PHARMACEUTICAL SOLUTIONS., SCHOTT AG, Gerresheimer AG, West Pharmaceutical Services, Inc., Dali Medical Devices, Stevanato Group, Credence MedSystems, Inc., Baxter, MAEDA INDUSTRY Co., Ltd., MedXL Inc, IRISYS, LLC, Sandoz International GmbH, Pfizer Inc., Vetter, Weigao Group, Fresenius Kabi, Catalent Inc and others.
Segmentation: By Product Design, By Material, By Usability, By End User, By Geography
Geography Covered: North America, Europe, Asia- Pacific, Rest of the World (Middle East, Africa, and South America)
Table of Contents
Prefilled Syringes Market Report Introduction
Prefilled Syringes Market Executive Summary
Regulatory and Patent Analysis
Prefilled Syringes Market Key Factors Analysis
Prefilled Syringes Market Porter’s Five Forces Analysis
COVID-19 Impact Analysis on Prefilled Syringes Market
Prefilled Syringes Market Layout
Prefilled Syringes Market Global Company Share Analysis – Key 3-5 Companies
Prefilled Syringes Market Company and Product Profiles
DelveInsight’s “Pediatric Growth Hormone Deficiency (PGHD) Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Pediatric Growth Hormone Deficiency (PGHD), historical and forecasted epidemiology as well as the Pediatric Growth Hormone Deficiency (PGHD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Address:304 S. Jones Blvd #2432
State: New York
Country: United States